MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Beyond initial clinical phenotype of Madelung disease: Myoclonus, gait disorder and multisystem involvement led to genetic diagnosis

    R. López-Blanco, A. Rojo-Sebastián, M.H. Torregrosa-Martínez, M. Molina-Sánchez, A. Blázquez-Encinar, M.Á. Martín-Casanueva (Madrid, Spain)

    Objective: To report the clinical phenotype of an uncommon hereditary systemic disease with slowly progressive gait and movement disorder with genetic identification of two concurrent…
  • 2016 International Congress

    Fahr’s syndrome in a Filipino female with hearing loss and polycystic ovaries: A case report

    P.D. Dadgardoust, R.L. Rosales (Manila, Philippines)

    Objective: The objective of this case report is to document a case of Fahr's syndrome including its varied clinical manifestations. Background: Idiopathic basal ganglia calcification,…
  • 2016 International Congress

    Post-anoxic myoclonus: Timing matters

    K.G. Su, A.L. Hiller (Portland, OR, USA)

    Objective: To highlight that timing of post-anoxic myoclonus following initial anoxic injury can result in markedly different outcomes. Background: Post-anoxic myoclonus is typically considered a…
  • 2016 International Congress

    Myoclonus complicating chickenpox: A case report

    F. Imounan, N. Daoudi (Meknes, Morocco)

    Objective: To report myoclonus and other movements disorders complicating chickenpox. Background: The meningoencephalitis is a rare complication of chickenpox. The occurrence of movements disorders is…
  • 2016 International Congress

    Hemifacial spasm – Therapeutic assessment of botulinum toxin

    H.A.G. Teive, J.P. Matisti, A.D. Kleinfelder, N.B. Galli (Curitiba, Brazil)

    Objective: To evaluate the long-term effect of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm (HFS) in a large group of patients…
  • 2016 International Congress

    Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome

    P. Termsarasab, S.J. Frucht (New York, NY, USA)

    Objective: To describe two patients with prostate cancer and identical phenotypes of likely paraneoplastic unilateral leg myoclonus. Background: Paraneoplastic movement disorders (PMDs) in prostate cancer…
  • 2016 International Congress

    How do we clinically distinguish subtypes of myoclonus? A retrospective study

    R. Zutt, J.W. Elting, H. van der Hoeven, F. Lange, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: To evaluate the accuracy of clinical phenotyping in a heterogeneous cohort of patients presenting with myoclonus and to determine clinical characteristics. Furthermore, we studied…
  • 2016 International Congress

    Transient myoclonic state in the elderly: A new entity in the classification of myoclonus

    T. Hashimoto, T. Doden, H. Sato (Matsumoto, Japan)

    Objective: To clarify the clinical picture of transient myoclonic state in elderly patients and to establish a position in the classification of myoclonus. Background: Transient…
  • 2016 International Congress

    Opsoclonus myoclonus ataxia syndrome in a seronegative patient with disseminated cryptococcosis: The first case report

    K. Sakdisornchai, J. Sringean, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To describe a 56-year-old man who presented with OMA due to disseminated cryptococcosis. Background: Opsoclonus-myoclonus-ataxia syndrome (OMA) is a rare neurological syndrome,characterized by a…
  • 2016 International Congress

    Topiramate responsive adult-onset opsoclonus myoclonus ataxia syndrome

    Y. Degirmenci, H. Kececi (Duzce, Turkey)

    Objective: Opsoclonus myoclonus ataxia (OMA) is a rare neurological syndrome characterized with with autoimmune background. However the exact pathophysiology is not clear. Most common underlying…
  • « Previous Page
  • 1
  • …
  • 1614
  • 1615
  • 1616
  • 1617
  • 1618
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley